This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
If you're over 50 and haven't saved for retirement, it's not too late. Learn essential steps to secure your financial future.
28,655 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Pennsylvania is weighing a tax move that would extend the state's telecom gross receipts tax to digital advertising. ...
The latest update on the darrell sheets toxicology report adds new public detail to a high-profile case. This piece b...
A new, secretive cargo delivery concept tested by SpaceX could reshape global logistics. This investor-focused overvi...
Longbridge Financial and Friday Harbor unveiled a joint AI pre-underwriting platform designed to flag issues early in...
As SpaceX moves deeper into the public market, investors face a volatile ride. This article lays out credible scenari...
Celsius founder Alex Mashinsky has filed to vacate a 12-year crypto fraud sentence, signaling a dramatic turn in a ca...
A public reflection on relationships can double as a financial guide. This article pulls lessons from a famous split ...
June brings three key events that can move Disney stock. This guide explains the dates Disney stock investors should ...
EU DAC8 and UK CARF rules are now driving tax reporting for 2027. As providers capture 2026 activity, investors shoul...
Micron stock hit a fresh all-time high as AI momentum and cloud demand boost memory-chip demand. This guide breaks do...
NVIDIA, under Jensen Huang, has built more than chips—it's crafted an AI compute ecosystem. This article explains why...